Claude能自己设计蛋白质了，比传统方法快多了，还和两家生物公司合作验证了效果。
Claude模型在蛋白质设计任务中表现出色，成功从零开始设计出针对14个目标的蛋白质结合物。这一过程仅需人类专家编写提示词，Claude便能自主完成设计工作。随后，Adaptyv Bio和Twist Bioscience公司独立验证了Claude设计的蛋白质功能。
Many drugs work by binding to a specific target in the body and blocking or changing what it does. A...
Many drugs work by binding to a specific target in the body and blocking or changing what it does. An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant weeks or months of expert work per target, sifting through a large number of candidates to identify the few that work. We wanted to test if Claude could successfully design novel protein binders from scratch (also called de novo design). With a protein design prompt written by a human expert, Claude autonomously designed protein binders against 14 out of 15 targets. We then worked with Adaptyv Bio and Twist Bioscience, who independently built and tested the proteins Claude designed. Your browser does not support the video tag. 🔗 View on Twitter 💬 172 🔄 265 ❤️ 2766 👀 185141 📊 507 ⚡